Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over 1,000 associates are guided by our diverse leadership team and female president that prioritize a culture of collaboration, engagement, diversity, and inclusion. Molecular Devices is proud to be part of Danaher. Danaher’s science and technology leadership puts Molecular Devices’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day. To learn more about how Molecular Devices helps fast-track scientific discovery, visit www.moleculardevices.com.
External link for Molecular Devices
3860 North First St
San Jose, CA 95134, US
Eskdale Road
Wokingham, England RG41 5TS, GB
Molecular Devices reposted this
Check out the Poster Presentation by Teresa Castaño Martínez, PhD at #SLAS2024 in Barcelona 👏 "Leveraging the Molecular Devices SpectraMax® i3x and the Transcreener® ADP2 Assay for Discovery of POLQ Helicase Inhibitors" in collaboration with BellBrook Labs 🤝 For more resources such as application notes, webinars and posters, visit the resource hub on our website: https://lnkd.in/ebfDbX57]
Our famous Imaging User Meeting returns! This year, our Advanced Imaging and Organoid Technologies User Meeting will be held in London, with a special focus on overcoming the challenges within complex imaging and 3D biology workflows. Tickets and a full agenda will be announced very soon. Register your interest and be the first to find out the latest news on this exciting event. https://lnkd.in/ebqW6UGS
Vicky Marsh Durban, Ph. D., our Director of Custom Organoid Services, is committed to helping researchers access large batches of standardized, assay-ready organoids for high-throughput screening, made using our patent-pending bioprocess technology. Check out her latest published perspectives on these topics and more: https://ow.ly/gPiv50Su5n1. 👩🔬 Organoids Evolve from Academic Marvel to Industrial Tool: https://lnkd.in/gXzve9td 👩🔬 A Decade of Transformation: How Organoids are Redefining Drug Development: https://lnkd.in/gnDa_i5r 👩🔬 Organoid Industrialization: https://lnkd.in/gw4e-nAa 👩🔬 Improving Drug Development: Molecular Devices and Cellesce Aim to Advance the Use of Organoids: https://lnkd.in/gv57YG-M #3dbiology #3dcellculture #organoids #drugdiscovery #drugscreening #drugdevelopment #diseasemodeling #labautomation #ai #machinelearning #deeplearning #highcontentimaging #highcontentscreening #scienceandtechnology #pharma #geneeditting #cellculture #pdo #imageanalysis
📰 In the Summer 2024 edition of Drug Discovery World, Diana Spencer examines the most recent advancements in high-throughput screening technologies for drug discovery and their potential to expedite therapeutic development: https://ow.ly/cnIH50Stkl3. During her discussion with Shan D., Vice President of Strategy and Innovation at Molecular Devices, Shan emphasizes the significance of automated cell culture and how our CellXpress.ai Automated Cell Culture System offers a solution for researchers that incorporates machine learning to enhance processes like media exchange, plating, passaging, organoid monitoring, endpoint assays, and complex image analysis—ultimately increasing both productivity and reproducibility in drug screening. #3dbiology #3dcellculture #organoids #drugdiscovery #drugscreening #drugdevelopment #diseasemodeling #labautomation #ai #machinelearning #deeplearning #highcontentimaging #highcontentscreening #scienceandtechnology #pharma #geneeditting #cellculture #pdo #imageanalysis
Wrapping Up Pride Month at Danaher, Molecular Devices, and IDBS: A Month of Celebration, Learning, and Solidarity As Pride Month draws to a close, we reflect on the vibrant and meaningful activities that brought our team together in celebration of diversity and inclusion. Here’s a look back at the highlights of June: 🌈 Kickoff Event: Pride Flag Raising We started the month with a historic flag-raising event at Danaher Headquarters, joined by our global offices in San Jose, Austria, Woking, and Boston. This monumental moment was a powerful symbol of our commitment to diversity, equity, and inclusion. 📚 Educational Webinars and Speaker Events Our educational webinars and panel discussions provided valuable insights into LGBTQ+ history and allyship. We were honored to host Andrew Gelwicks, author of "The Queer Advantage," who shared inspiring stories from his book and led a thought-provoking panel discussion with OUT leaders at Danaher. 🎉 Social Events: Pride Mocktail Happy Hour and Inter ARG Event We enjoyed a fun and educational Pride Mocktail Happy Hour, complete with live demonstrations and trivia sessions that highlighted the rich tapestry of LGBTQ+ history. The Inter ARG Pride Event brought together colleagues from around the globe to share their unique experiences and celebrate intersectionality within the LGBTQ+ community. 🎵 Pride Playlist and Charity Drive Our Pride Playlist, curated with contributions from our team, resonated with the spirit of Pride. Additionally, our fundraiser for The Trevor Project demonstrated our collective support for LGBTQ+ youth, raising significant funds for this vital organization. Thank you to everyone who participated and contributed to making Pride Month a success. Let's continue to champion inclusivity and celebrate diversity all year round. #PrideMonth #DiversityAndInclusion #LGBTQSupport #CelebrateDiversity #LoveIsLove #Pride2024
Molecular Devices reposted this
🎉 That’s a wrap on Federation of European Neuroscience Societies - FENS Forum 2024 in Vienna! Thank you to everyone who visited our booth, and to our partners and colleagues who made this show a success. If you’d like to learn more about the topics covered at the show, here’s a good place to start: moleculardevices.com #Neuroscience #3DBiology #AutomatedWorkflow #DrugScreening #DrugDiscovery #Patchclamp
Molecular Devices reposted this
🎉 That’s a our last day at Federation of European Neuroscience Societies - FENS Forum 2024 in Vienna! We will be here until 2 p.m., so be sure to stop by😉 #neuroscience #patchclamp #drugdiscovery #drygsafety #highthroughputscreening #microplatereaders #3DBiology
#3Dcellculture is a vital part of many #3DBiology workflows - but the process can be difficult, time-consuming, and result in highly variable cell cultures that lead to less reliable results. But there is a better way. Watch our webinar to discover how an automated solution can transform this complex task into a simple, reproducible process - no matter how complex the protocols involved. https://lnkd.in/eE4NCWHD
Molecular Devices reposted this
Day 3 at Federation of European Neuroscience Societies - FENS FORUM 2024 in Vienna! Our enthusiastic team is eager to talk with you about your research needs and introduce our innovations in #3DBiology, #Imaging, #DrugScreening, #LabAutomation, and #Electrophysiology. Join us at booth 500 while we have all the chocolates to give away😉 Meet the team: Valeria Vitale, Andrea Zecchini, Sonia Cavaliere, Jeffrey Tang, PhD, Georgy Pyatakov #patchclamp #neuroscience #fens #drugdiscovery #drugsafety
Oksana Sirenko, Ph.D., our Senior Manager of Assay Development, has loads of expertise working with complex cell-based models for 3D biology and optimizing their use with automated, AI-enabled technologies. Check out her latest published perspectives on these topics and more: https://ow.ly/l5vY50SmQGi. 🎙️ Enhancing 3D Cell Culture Imaging: https://ow.ly/4EaT50SmQGf 🎙️ 3D Imaging of Organoid Cultures: https://ow.ly/h4ie50SmQGg 🎙️ Selecting the Right Cell-Based Assay: https://ow.ly/WjB850SmQGj 🎙️ Gene Editing in Organoids: Accounting for Complexity in Drug Discovery: https://ow.ly/RClb50SmQGh #3dbiology #3dcellculture #organoids #drugdiscovery #drugscreening #drugdevelopment #diseasemodeling #labautomation #ai #machinelearning #deeplearning #highcontentimaging #highcontentscreening #scienceandtechnology #pharma #geneeditting #cellculture #pdo #imageanalysis